Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
Conditions: Rhegmatogenous Retinal Detachment; Proliferative Vitreoretinopathy Intervention: Drug: Netarsudil Ophthalmic Sponsor: Massachusetts Eye and Ear Infirmary Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
RCT on Red Light Treatment for Myopic Minors' Retinal Impact
Condition: Red Laser Light-Induced Retinopathy of Both Eyes (Diagnosis) Intervention: Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
Conditions: Rhegmatogenous Retinal Detachment; Proliferative Vitreoretinopathy Intervention: Drug: Netarsudil Ophthalmic Sponsor: Massachusetts Eye and Ear Infirmary Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
RCT on Red Light Treatment for Myopic Minors' Retinal Impact
Condition: Red Laser Light-Induced Retinopathy of Both Eyes (Diagnosis) Intervention: Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
Conditions: Rhegmatogenous Retinal Detachment; Proliferative Vitreoretinopathy Intervention: Drug: Netarsudil Ophthalmic Sponsor: Massachusetts Eye and Ear Infirmary Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
RCT on Red Light Treatment for Myopic Minors' Retinal Impact
Condition: Red Laser Light-Induced Retinopathy of Both Eyes (Diagnosis) Intervention: Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
Conditions: Rhegmatogenous Retinal Detachment; Proliferative Vitreoretinopathy Intervention: Drug: Netarsudil Ophthalmic Sponsor: Massachusetts Eye and Ear Infirmary Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
RCT on Red Light Treatment for Myopic Minors' Retinal Impact
Condition: Red Laser Light-Induced Retinopathy of Both Eyes (Diagnosis) Intervention: Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
Conditions: Rhegmatogenous Retinal Detachment; Proliferative Vitreoretinopathy Intervention: Drug: Netarsudil Ophthalmic Sponsor: Massachusetts Eye and Ear Infirmary Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2023 Category: Research Source Type: clinical trials
Delaying the Onset of Nearsightedness Until Treatment Study
Condition: Myopia Intervention: Drug: Atropine Ophthalmic Sponsors: Ohio State University; University of Houston; State University of New York; Pennsylvania College of Optometry; Southern California College of Optometry at Marshall B. Ketchum University; University of California, Berkeley; Stanford University; Case Western R eserve University; Illinois College of Optometry; Indiana University; New England College of Optometry; University of the Incarnate Word; Southern College of Optometry; University of Missouri, St. Louis Not yet recru...
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
